Proteomics-based phenotypic classification of non-smallcell lung cancer

被引：0
|
作者：
Berkovska, O. [1 ]
Mermelekas, G. [1 ]
Orre, L. [1 ]
Lehtio, J. [1 ]
机构：
[1] Karolinska Inst, Oncol Pathol, Stockholm, Sweden
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1292
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2264P
引用
收藏
页码：S1163 / S1164
页数：2
相关论文
共 50 条
  • [11] Deep-learning-based automated delineation and classification of metabolic tumor volume in non-smallcell lung cancer in [18F]FDG-PET/CT
    Nikulin, P.
    Fitis, E.
    Hofheinz, F.
    Kotzerke, J.
    Furth, C.
    Amthauer, H.
    Elicin, O.
    Stutz, E.
    Krcek, R.
    Zschaeck, S.
    van den Hoff, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S350 - S351
  • [12] Five-Year Clinical Outcomes of Perioperative Nivolumab and Chemotherapy in Stage III Non-SmallCell Lung Cancer (NADIM Trial)
    Provencio, M.
    Nadal, E.
    Insa, A.
    Campelo, M. R. Garcia
    Calvo, V.
    Palmero, R.
    Lazaro, M.
    Domine, M.
    Majem, M.
    Rodriguez-Abreu, D.
    Martinez-Marti, A.
    Carpeno, J. De Castro
    Cobo, M.
    Bernabe, R.
    Vinolas, N.
    Barneto, I.
    Viteri, S.
    Cruz-Bermudez, A.
    Romero, A.
    Massuti, B.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S54 - S55
  • [13] Long-Term Prognosis of Patients Undergoing Trimodality Therapy for Locally Advanced Non-SmallCell Lung Cancer
    Okada, K.
    Suzawa, K.
    Ryuko, T.
    Tomioka, Y.
    Tanaka, S.
    Shien, K.
    Miyoshi, K.
    Okazaki, M.
    Sugimoto, S.
    Suzuki, E.
    Soh, J.
    Toyooka, S.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S574 - S574
  • [14] Baseline neutrophil-lymphocyte ratio is associated with baseline and subsequent presence of brain metastases in advanced non-smallcell lung cancer
    Koh, Young Wha
    Choi, Jin-Hyuk
    Ahn, Mi Sun
    Choi, Yong Won
    Lee, Hyun Woo
    SCIENTIFIC REPORTS, 2016, 6
  • [15] Proteomics-based identification of alpha-enolase as a tumor antigen in non-small lung cancer
    Naka, Tetsuji
    He, Ping
    Serada, Satoshi
    Fujimoto, Minoru
    Kawase, Ichiro
    CANCER RESEARCH, 2006, 66 (08)
  • [16] A case of ALK-associated non-smallcell lung cancer with evidence of omental metastasis 6 years after initial presentation
    Kulkarni, Sameer
    Kabbinavar, Fairooz
    Eshaghian, Shahrooz
    LUNG CANCER MANAGEMENT, 2013, 2 (03) : 199 - 204
  • [17] Efficacy of tumor treating fields (TTFields) and anti-PD-1 in non-smallcell lung cancer (NSCLC) preclinical models
    Giladi, M.
    Voloshin, T.
    Talyitzhaki, O.
    Weinberg, U.
    Kirson, E. D.
    ANNALS OF ONCOLOGY, 2017, 28
  • [18] Treatment of stage IIIA-N2 EGFR-mutant non-smallcell lung adenocarcinoma
    Zhao, Jinlong
    Jiang, Zazhi
    Du, Jiahui
    Yang, Peng
    JOURNAL OF THORACIC DISEASE, 2019, 11 (01) : 263 - 265
  • [19] Effects of SMYD2-mediated EML4-ALK methylation on the signaling pathway and growth in non-smallcell lung cancer cells
    Wang, Rui
    Deng, Xiaolan
    Yoshioka, Yuichiro
    Vougiouklakis, Theodore
    Park, Jae-Hyun
    Suzuki, Takehiro
    Dohmae, Naoshi
    Ueda, Koji
    Hamamoto, Ryuji
    Nakamura, Yusuke
    CANCER SCIENCE, 2018, 109 : 1217 - 1217
  • [20] LcProt: Proteomics-based identification of plasma biomarkers for lung cancer multievent, a multicentre study
    Liang, Hengrui
    Wang, Runchen
    Cheng, Ran
    Ye, Zhiming
    Zhao, Na
    Zhao, Xiaohong
    Huang, Ying
    Jiang, Zhanpeng
    Li, Wangzhong
    Zheng, Jianqi
    Deng, Hongsheng
    Jiang, Yu
    Lin, Yuechun
    Yan, Yun
    Song, Lei
    Li, Jie
    Xu, Xin
    Liang, Wenhua
    Liu, Jun
    He, Jianxing
    CLINICAL AND TRANSLATIONAL MEDICINE, 2025, 15 (01):
12345